<DOC>
	<DOCNO>NCT01244061</DOCNO>
	<brief_summary>The main purpose study compare effectiveness safety re-treatment smoker varenicline placebo smoke cessation last 4 week 12 week course treatment . The study also assess whether smoker remain abstinent Week 24 ( 12 week end treatment ) Week 52 ( 40 week end treatment ) .</brief_summary>
	<brief_title>A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<criteria>Smokers age 18 year want stop smoking Smokers smoke average least 10 cigarette per day last 4 week Smokers try stop smoking least varenicline , take varenicline least 2 week The last attempt stop smoking must least 3 month enter study Individuals tolerate varenicline well previously , current prior medical psychiatric history would make entry trial inadvisable Individuals previously participate clinical trial varenicline Individuals participate another smoking cessation trial within last 3 month , drug trial within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>